These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30768227)

  • 1. Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome).
    Cernichiaro-Espinosa LA; Patel NA; Bauer MS; Negron CI; Fallas B; Pogrebniak A; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Feb; 50(2):e33-e37. PubMed ID: 30768227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUCCESSFUL TREATMENT OF REFRACTORY PROLIFERATIVE RETINOPATHY OF INCONTINENTIA PIGMENTI BY INTRAVITREAL RANIBIZUMAB AS ADJUNCT THERAPY IN A 4-YEAR-OLD CHILD.
    Ho M; Yip WWK; Chan VCK; Young AL
    Retin Cases Brief Rep; 2017 Fall; 11(4):352-355. PubMed ID: 27472514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for incontinentia pigmenti.
    Shah PK; Bachu S; Narendran V; Kalpana N; David J; Srinivas CR
    J Pediatr Ophthalmol Strabismus; 2013 Oct; 50 Online():e52-4. PubMed ID: 25313552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal injection of ranibizumab in severe retinopathy of incontinentia pigmenti.
    Ni Y; Huang X; Ruan L; Xue K; Yu J; Peng J; Zhao P
    J AAPOS; 2018 Aug; 22(4):325-327.e3. PubMed ID: 29630932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti - a case report.
    Kunzmann S; Ngyuen T; Stahl A; Walz JM; Nentwich MM; Speer CP; Ruf K
    BMC Pediatr; 2019 Oct; 19(1):353. PubMed ID: 31615465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of retinopathy of incontinentia pigmenti by anti-vascular endothelial growth factor].
    Wang X; Liang JH
    Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):294-301. PubMed ID: 30982292
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions.
    Tomomatsu Y; Tomomatsu T; Takamura Y; Gozawa M; Arimura S; Takihara Y; Inatani M
    Acta Ophthalmol; 2016 May; 94(3):e225-30. PubMed ID: 25989706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion.
    Fong KC; Barry C; McAllister IL
    Clin Exp Ophthalmol; 2009 Jul; 37(5):485-9. PubMed ID: 19624345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F; Astam N; Ozmert E
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Follow-up of Treated and Untreated Retinopathy in Incontinentia Pigmenti: Analysis of Peripheral Vascular Changes and Incidence of Retinal Detachment.
    Chen CJ; Han IC; Tian J; Muñoz B; Goldberg MF
    JAMA Ophthalmol; 2015 May; 133(5):542-8. PubMed ID: 25695859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice.
    Khan M; Wai KM; Silva FQ; Srivastava S; Ehlers JP; Rachitskaya A; Babiuch A; Deasy R; Kaiser PK; Schachat AP; Yuan A; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2017 Jun; 48(6):465-472. PubMed ID: 28613352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-contact ultra-widefield retinal imaging and fundus fluorescein angiography of an infant with incontinentia pigmenti without sedation in an ophthalmic office setting.
    Patel CK; Fung TH; Muqit MM; Mordant DJ; Geh V
    J AAPOS; 2013 Jun; 17(3):309-11. PubMed ID: 23607978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
    Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescein angiographic findings in a male infant with incontinentia pigmenti.
    DeVetten G; Ells A
    J AAPOS; 2007 Oct; 11(5):511-2. PubMed ID: 17498989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab.
    Hajrasouliha AR; Garcia-Gonzales JM; Shapiro MJ; Yoon H; Blair MP
    Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):255-259. PubMed ID: 28297039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid regression of retinal neovascularization following intravitreal bevacizumab in branch retinal vein occlusion imaged by optical coherence tomography angiography.
    Brar M; Grewal DS; Sharma M; Grewal SPS
    Indian J Ophthalmol; 2018 Apr; 66(4):572. PubMed ID: 29582824
    [No Abstract]   [Full Text] [Related]  

  • 18. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
    Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
    Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up.
    Arevalo JF; Lasave AF; Wu L; Maia M; Diaz-Llopis M; Alezzandrini AA; Brito M;
    Retina; 2017 Feb; 37(2):334-343. PubMed ID: 27429384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.